Reaction

Renal Tubular Injury reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,142 reports · 56 co-occurring drugs

As of the last recalculation, Renal Tubular Injury appears in 1,142 FAERS reports alongside 56 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 92.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Basiliximab	57	92.9	93.4
Tacrolimus Ointment 0.1%	323	65.5	65.7
Tacrolimus Extended-Release Capsules	323	65.3	65.5
Sirolimus	44	61.9	62.1
Tacrolimus	364	61.7	61.8
Busulfan	46	55.5	55.6
Mycophenolate Mofetil	255	43.8	43.9
Mycophenolate Mofetil Hydrochloride	255	43.7	43.8
Ampicillin	17	38.0	38.0
Ampicillin Sodium	17	38.0	38.0
Valganciclovir Hydrochloride Powder,	24	36.6	36.7
Anti-Thymocyte Globulin (Rabbit)	15	34.3	34.4
Mycophenilic Acid	37	33.6	33.7
Benzonatate	27	30.5	30.5
Valganciclovir	29	28.7	28.8
Valganciclovir Hydrochloride	29	28.7	28.8
Mycophenolic Acid	47	27.9	27.9
Tobramycin Solution	18	27.7	27.8
Tobramycin Sulfate	18	26.9	26.9
Ganciclovir	14	25.2	25.3
Ganciclovir Sodium	14	24.4	24.4
Ifosfamide	26	22.5	22.6
Thiotepa	10	19.2	19.3
Entecavir	12	18.9	18.9
Vancomycin	56	18.5	18.5
Vancomycin Hydrochloride	62	18.1	18.1
Everolimus Tablets	15	16.5	16.5
Rifampin	13	16.4	16.4
Cyclosporine	92	16.3	16.3
Mesna Injection	7	15.5	15.5
Mesna	7	15.2	15.3
Melphalan Hydrochloride	19	14.0	14.0
Tobramycin	18	13.8	13.9
Melphalan	17	13.8	13.8
Pemetrexed	16	13.8	13.8
Fludarabine Phosphate	27	12.8	12.8
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	6	12.2	12.2
Piperacillin Sodium,Tazobactam Sodium	17	11.8	11.8
Cefepime	9	11.5	11.5
Pemetrexed Disodium	23	11.2	11.2
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	11	11.2	11.2
Tenofovir Disoproxil Fumarate Tablets	5	10.6	10.6
Cyclophosphamide Injection, Solution	92	10.2	10.2
Cyclophosphamide	92	10.2	10.2
Cyclophosphamide For Injection	92	10.2	10.2
Tenofovir Disoproxil Fumarate	17	9.5	9.5
Emtricitabine And Tenofovir Disoproxil Fumarate	21	8.5	8.5
Pembrolizumab	43	7.7	7.7
Gemcitabine	16	7.5	7.5
Abiraterone	5	6.7	6.7
Gemcitabine Hydrochloride	19	6.6	6.6
Iohexol	3	6.6	6.6
Alirocumab	8	5.8	5.8
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	3	5.4	5.4
Lenvatinib	9	5.0	5.0
Relugolix	5	3.9	3.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.